Advantages and safety of local treatment with MMC/Beriplast P for cancer tumors

Cancer Chemotherapy and Pharmacology

Volumn 38, Issue 6, 1996, Pages 508-512

  Matsuoka, Hideo ^a   Yano, Kumiyo ^a   Katsuta, Yasaburo ^a   Morita, Masaru ^b   Kounoe, Syunji ^b   Seo, Yousuke ^b   Saito, Takao ^b   Tomoda, Hirotsugu ^b  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

^b National Hospital Organization   (Japan)

Author keywords

Beriplast P; Local treatment; Mitomycin C

Indexed keywords

DRUG CARRIER; FIBRIN GLUE; MITOMYCIN C;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOAVAILABILITY; CANCER GROWTH; CONTROLLED STUDY; DRUG DETERMINATION; DRUG RELEASE; DRUG SAFETY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INTRATUMORAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADHESIONS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; AORTA; CARCINOMA, SQUAMOUS CELL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; FIBRIN TISSUE ADHESIVE; INTESTINAL DISEASES; MALE; MICE; MICE, INBRED BALB C; MITOMYCIN; NEOPLASM TRANSPLANTATION; RATS; RATS, INBRED F344; SARCOMA, EXPERIMENTAL; TUMOR CELLS, CULTURED; VENAE CAVAE;

EID: 0029802303     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050519     Document Type: Article

References (11)

1. Cova D, Luporini A, Baruffi S, Puster R, Bollina R, Scafuro E, Diterlizzi M, Cozzi C (1995) Digestive tract tumors. In: Mitomycin C. Clinical review. Edizioni Minerva Medica, Turin, p 46
2. Hagiwara A, Takahashi T, Lee R, Ueda T, Takeda M, Itoh T (1983) Selective delivery of high level of mitomycin C to peritoneal carcinomatosis using a new dosage form for cancer chemotherapy. Akita J Med 10:187
3. Hagiwara A, Takahashi T, Kojima O, Sawai K, Yamaguchi T, Yamane T, Taniguchi H, Kitamura A, Noguchi A, Seiki K, Sakakura C (1992) Prophylaxis with carbon-adsorbed mitomycin against peritoneal reccurrence of gastric cancer. Lancet 339:629
4. Isao S, Hirohito N, Tsutomu T, Hideki M, Takushi M, Takashi S, Takesada M (1992) Effect of OK-432 fibrinogen mixture by intratumoral injection to lymph nodes of colorectal cancer host. Biotherapy 6:703
5. Ishihara K, Yamazaki N (1992) Extravasation of cancer chemotherapeutic drugs. Skin Cancer 7:117
6. Masuike T, Ohdake J, Ono E, Takemoto Y (1991) Chromatographic determination method and stability of mitomycin C in plasma and tissues. Igaku-no-ayumi 157:383
7. Pfeiffer P, Bennedbek O, Bertelsen K (1990) Intraperitoneal carboplatin in the treatment of minimal residual ovarian cancer. Gynecol Oncol 36:306
8. Philips FS (1960) Pharmacology of mitomycin C. I. Toxicity and pathologic effects. Cancer Res 20:1354
9. Sugitachi A, Hayashi R, Kido T, Sato E, Miyaji N (1989) A new approach to targeting chemotherapy. Jpn J Artif Organs 18:32
10. Tabata Y, Ikeda Y (1989) Protein precoating of polylactide microspheres containing a lipophilic immunopotentiator for enhancement of macrophage phagocytosis and activation. Pharm. Res 6:296
11. Weinstein JN (1984) Liposomes as drug carriers in cancer therapy. Cancer Treat Rep 68:127